CausalSentinel

Protein Dossier — PRSS2 (Trypsin-2)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Multiple sclerosis -0.338 0.088 1.24e-04 Wald ratio 1 trans NA
Ulcerative colitis -0.242 0.0678 3.55e-04 Wald ratio 1 trans NA
Age at menopause -0.358 0.107 8.58e-04 Wald ratio 1 trans NA
Diagnoses - main ICD10: K43 Ventral hernia 0.307 0.0952 0.00127 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: K43 Ventral hernia 0.307 0.0952 0.00127 Inverse variance weighted 2 trans NA
Myocardial infarction 0.128 0.0413 0.00201 Inverse variance weighted 2 trans NA
Myocardial infarction 0.128 0.0413 0.00201 Inverse variance weighted 2 trans NA
Non-cancer illness code self-reported: psoriasis -0.335 0.114 0.00332 Inverse variance weighted 2 trans NA
Non-cancer illness code self-reported: psoriasis -0.335 0.114 0.00332 Inverse variance weighted 2 trans NA
Neo-openness to experience -1.12 0.389 0.00403 Wald ratio 1 trans NA
Neuroblastoma -0.616 0.224 0.00588 Wald ratio 1 trans NA
Birth length -0.12 0.0436 0.00603 Wald ratio 1 trans NA
…and 153 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-5034_79_1 Trypsin 2 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

43 association rows across 16 traits (39 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
CTRB1/PRSS2 protein level ratio 3e-340 rs10952532 1 GCST90314308 no MR -> candidate analysis
CPB1/PRSS2 protein level ratio 6e-339 rs10952532 1 GCST90314211 no MR -> candidate analysis
PLA2G1B/PRSS2 protein level ratio 4e-152 rs10952532 1 GCST90315665 no MR -> candidate analysis
PRSS2 protein levels 2e-106 rs3752404 1 GCST90470343 no MR -> candidate analysis
Circulating PRSS2 levels 2e-101 rs4726588 1 GCST90860437 no MR -> candidate analysis
Alcoholic chronic pancreatitis 5e-40 rs2855983 26 GCST004860 no MR -> candidate analysis
CTRB1 protein levels 3e-21 rs1969595 1 GCST90468905 no MR -> candidate analysis
Trypsin-2 levels (PRSS2.5034.79.1) 3e-20 rs13229701 1 GCST90243126 no MR -> candidate analysis
Chronic pancreatitis (PheCode 577.2) 5e-17 rs2855972 2 GCST90480358 no MR -> candidate analysis
Serum levels of protein PRSS2 5e-14 rs10258394 1 GCST90088888 no MR -> candidate analysis
Trypsin-2 levels 3e-12 rs28706856 2 GCST90137836 no MR -> candidate analysis
Diseases of pancreas (PheCode 577) 3e-12 rs2855972 1 GCST90480360 no MR -> candidate analysis
…and 4 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 246 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
alcoholic pancreatitis 0.697 common-variant locus no MR -> candidate analysis
acute pancreatitis 0.503 common-variant locus no MR -> candidate analysis
chronic pancreatitis 0.505 common-variant locus no MR -> candidate analysis
pancreatitis 0.057 common-variant locus no MR -> candidate analysis

Of the 4 rows above, 4 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Trypsin-2)
gnomAD constraint pLI=3.2e-07, LOEUF=1.45 — LoF-tolerant
GWAS Catalog 105 unique SNPs / 209 rows
ClinVar 31 records; 22 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance